RNU7-136P

Across TCGA pan-cancer cohorts, RNU7-136P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU7-136P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU7-136P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-136P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

READ, LIHC, and MESO are the cancer types where RNU7-136P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	III,IV	0.096	0.756	<.001	90	view →
LIHC	DFS	Tertile	All	0.043	0.545	<.001	72	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	54	view →
ESCA	OS	Tertile	All	0.208	0.906	.010	36	view →
LUAD	DFS	Tertile	IV	0.109	0.714	.001	36	view →
SARC	DFS	Tertile	All	0.335	0.620	.010	21	view →
BLCA	OS	Tertile	III,IV	0.164	0.579	.011	18	view →
PRAD	OS	Tertile	All	0.572	0.883	<.001	18	view →
CESC	DFS	Tertile	All	0.525	0.824	.033	18	view →
GBM	DFS	Tertile	All	0.524	0.194	.043	9	view →
STAD	OS	Tertile	III,IV	0.413	0.645	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU7-136P–READ (DFS)

Open the READ breakdown →